CN111647094B - Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury - Google Patents

Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury Download PDF

Info

Publication number
CN111647094B
CN111647094B CN202010532378.1A CN202010532378A CN111647094B CN 111647094 B CN111647094 B CN 111647094B CN 202010532378 A CN202010532378 A CN 202010532378A CN 111647094 B CN111647094 B CN 111647094B
Authority
CN
China
Prior art keywords
nereis
polysaccharide
liver injury
protection effect
extracting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010532378.1A
Other languages
Chinese (zh)
Other versions
CN111647094A (en
Inventor
苏捷
廖登远
刘智禹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisheries Research Institute Of Fujian (fujian Aquatic Disease Prevention Center)
Original Assignee
Fisheries Research Institute Of Fujian (fujian Aquatic Disease Prevention Center)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisheries Research Institute Of Fujian (fujian Aquatic Disease Prevention Center) filed Critical Fisheries Research Institute Of Fujian (fujian Aquatic Disease Prevention Center)
Priority to CN202010532378.1A priority Critical patent/CN111647094B/en
Publication of CN111647094A publication Critical patent/CN111647094A/en
Application granted granted Critical
Publication of CN111647094B publication Critical patent/CN111647094B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Sustainable Development (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)

Abstract

An extraction method of nereis polysaccharide with auxiliary protection effect on chemical liver injury relates to the field of functional foods. The method comprises the following steps: 1) cleaning clamworm, freeze-drying with a freeze dryer, and pulverizing with a pulverizer to obtain clamworm powder; 2) adding clam worm powder into a phosphate buffer solution and mixing to obtain a mixture A; 3) adding trypsin to the mixture A to obtain a mixture B; 4) sequentially carrying out water bath and leaching on the mixture B, and separating to obtain a supernatant; 5) filtering the supernatant with ceramic membrane, precipitating with ethanol to obtain precipitate, washing the precipitate, and lyophilizing to obtain nereis polysaccharide. Nereid polysaccharide has protective effect on liver injury caused by T cells, and can reduce immune injury caused by T cells by regulating and controlling activity of T cells.

Description

Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury
Technical Field
The invention relates to the field of functional foods, in particular to a method for extracting nereis virens polysaccharide with an auxiliary protection effect on chemical liver injury.
Background
The liver is the most important organ of drug metabolism in the body. Chemical liver injury refers to liver injury caused by chemical hepatotoxic substances. These chemicals include alcohol, environmental chemical poisons and certain drugs. The liver, an important detoxifying organ of the human body, has dual blood supplies of hepatic artery and hepatic vein. Chemical substances can enter the liver through the portal vein of the gastrointestinal tract or systemic circulation for transformation, and thus the liver is vulnerable to toxic substances in the chemical substances. In the production process of both nature and human industry, some substances with toxicity to liver exist, which are called as "hepatotropic poisons", the poisons are generally susceptible and have short incubation period in people, and the pathological process is directly related to the infection dosage, and can cause hepatocyte necrosis, fatty deformation, liver cirrhosis and liver cancer of different degrees of liver. Canavalid protein A (Con A) is a specific T cell mitogen, and can accelerate the proliferation and differentiation of T cells, break the balance between helper T cell subsets, cause immunoregulation dysfunction, trigger uncontrolled immune response of organism, and activate immune cells such as macrophage, neutrophil, natural killer cell, etc. The liver is a main affected organ due to the characteristics of rich blood supply, low blood flow speed and the like, immune cells easily act on the liver, and molecules such as proinflammatory cytokines and reactive oxygen species are released, so that the liver is subjected to inflammatory injury.
Disclosure of Invention
The invention aims to solve the problems in the prior art and provides a method for extracting nereis polysaccharide with an auxiliary protection effect on chemical liver injury, which researches the auxiliary protection effect of the nereis polysaccharide on Con A-induced chemical liver injury through the full-value development of the nereis, develops instant special food and health-care functional food with the auxiliary protection effect on the chemical liver injury, strengthens the diversified development of nereis rear-end industrial chain products and improves the enriching driving effect of cultivation enterprises on surrounding farmers through the modes of medicine source base cultivation, product research and development, and store sales and production research.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury comprises the following steps:
1) cleaning clamworm, freeze-drying with a freeze dryer, and pulverizing with a pulverizer to obtain clamworm powder;
2) adding clam worm powder into a phosphate buffer solution and mixing to obtain a mixture A;
3) adding trypsin to the mixture A to obtain a mixture B;
4) sequentially carrying out water bath and leaching on the mixture B, and separating to obtain a supernatant;
5) filtering the supernatant with ceramic membrane, precipitating with ethanol to obtain precipitate, washing the precipitate, and lyophilizing to obtain nereis polysaccharide.
The Nereid comprises at least one of Perinereis aibuhitensis and Nereis schlegeli.
In the step 2), the volume ratio of the weight of the silkworm powder to the phosphate buffer is 1: 5-20.
The pH value of the phosphate buffer solution is 7.0-10.0.
In the step 3), the weight ratio of the trypsin to the silkworm powder is 1: 300-3000.
The enzymatic activity of the trypsin is 1000-5000U/mg.
In the step 4), the temperature of the water bath is 35-50 ℃, the time of the water bath is 1-8 hours, the leaching temperature is 50-90 ℃, and the leaching time is 1-5 hours.
In the step 4), the separation method for separating and obtaining the supernatant can adopt suction filtration or centrifugation.
In the step 5), the precipitate is washed by absolute ethyl alcohol, acetone and ether respectively.
Compared with the prior art, the technical scheme of the invention has the following beneficial effects:
nereid polysaccharide has protective effect on liver injury caused by T cells, can reduce immune injury caused by T cells by regulating and controlling activity of T cells, and has protective effect on liver injury caused by canavalin A and CCl by liver histopathological examination4The acute liver injury caused by the drug also has the auxiliary protection effect.
Drawings
FIG. 1 is a graph showing the data of the AST content in the serum of mice in each experimental group;
FIG. 2 is a data graph of ALT content in serum of mice of each experimental group.
Detailed Description
In order to make the technical problems, technical solutions and advantageous effects of the present invention clearer and clearer, the present invention is further described in detail below with reference to the accompanying drawings and embodiments.
Example 1
A method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury comprises the following steps:
1) cleaning perinereis aibuhitensis, freeze-drying with a freeze dryer, and pulverizing with a pulverizer to obtain powder;
2) adding the clam worm powder into a phosphate buffer solution with the pH value of 8.0 and mixing to obtain a mixture A, wherein the volume ratio of the weight of the clam worm powder to the phosphate buffer solution is 1: 10;
3) adding trypsin (enzyme activity 2500U/mg) into the mixture A to obtain a mixture B, wherein the weight ratio of the trypsin to the silkworm powder is 1: 300;
4) carrying out water bath at 45 ℃ for 5h, leaching at 80 ℃ for 2h, centrifuging or carrying out suction filtration, and taking supernatant;
5) filtering the supernatant with ceramic membrane, precipitating with ethanol to obtain precipitate, washing the precipitate with anhydrous ethanol, acetone and diethyl ether, and lyophilizing to obtain Nereis Japonica polysaccharide.
Example 2
A method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury comprises the following steps:
1) cleaning Nereid wartii, lyophilizing, and pulverizing to obtain Nereis Japonica powder;
2) adding the clam worm powder into a phosphate buffer solution with the pH value of 10.0 and mixing to obtain a mixture A, wherein the volume ratio of the weight of the clam worm powder to the phosphate buffer solution is 1: 20;
3) adding trypsin (with the enzyme activity of 5000U/mg) into the mixture A to obtain a mixture B, wherein the weight ratio of the trypsin to the silkworm powder is 1: 3000;
4) carrying out 35 ℃ water bath on the mixture B for 8h, leaching at 90 ℃ for 1h, centrifuging or carrying out suction filtration, and taking supernatant;
5) filtering the supernatant with ceramic membrane, precipitating with ethanol to obtain precipitate, washing the precipitate with anhydrous ethanol, acetone and diethyl ether, and lyophilizing to obtain Nereis Japonica polysaccharide.
Example 3
A method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury comprises the following steps:
1) cleaning perinereis aibuhitensis, freeze-drying with a freeze dryer, and pulverizing with a pulverizer to obtain powder;
2) adding the clam worm powder into a phosphate buffer solution with the pH value of 7.0 and mixing to obtain a mixture A, wherein the volume ratio of the weight of the clam worm powder to the phosphate buffer solution is 1: 5;
3) adding trypsin (enzyme activity is 1000U/mg) into the mixture A to obtain a mixture B, wherein the weight ratio of the trypsin to the silkworm powder is 1: 1500;
4) carrying out water bath at 50 ℃ for 1h, leaching at 50 ℃ for 5h, centrifuging or carrying out suction filtration, and taking supernatant;
5) filtering the supernatant with ceramic membrane, precipitating with ethanol to obtain precipitate, washing the precipitate with anhydrous ethanol, acetone and diethyl ether, and lyophilizing to obtain Nereis Japonica polysaccharide.
The nereis polysaccharide prepared in example 1 was subjected to relevant experimental tests, as follows:
1. selecting adult male mice (18-22 g), wherein each group comprises 10-15 mice, and performing experiments in 6 groups, namely a control group, a model group, a No. 1 sample group, a No. 2 sample group, a No. 3 sample group and a positive group;
2. the mice of the control group and the model group are normally fed with feed and purified water; feeding nereis polysaccharide with different dosages for 30 days in 3 groups of sample groups, and feeding for 2 times every day, wherein the sample group 1 is 200mg/kg, the sample group 2 is 400mg/kg, and the sample group 3 is 600 mg/kg; the positive group is fed with prednisone acetate 7.8mg/kg every day;
3. the model group, the positive group and each sample group are administered with the canavalin A with the dose of 20mg/kg through the tail vein once at the end of the experiment, after 8 hours of fasting, the canavalin A is anesthetized by intraperitoneal injection of 60mg/kg BW pentobarbital sodium solution, the abdominal aorta is subjected to blood collection, and the liver tissue is taken for detection of each index and pathological histological examination. Detecting the body weight, alanine Aminotransferase (ALT) in serum, aspartate Aminotransferase (AST) in serum, Lactate Dehydrogenase (LDH) in serum and liver histopathological changes of the mice.
As shown in fig. 1 and fig. 2, the nereis polysaccharide can significantly reduce the content of AST and ALT in the serum of the mice with liver injury induced by the sword bean protein, which indicates that the nereis polysaccharide has liver protection effect on the mice with liver injury induced by the sword bean protein.
As shown in Table 1, the influence of nereis polysaccharide on the serum INF-gamma and TNF-alpha of mice with acute liver injury induced by jack bean protein A is shown. Compared with a normal control group, the level of INF-gamma and TNF-alpha in the serum of the mouse in the model group is obviously increased; compared with the model group, the levels of INF-gamma and TNF-alpha in the serum of the mice of the positive group and each sample group are obviously reduced.
TABLE 1
Group of INF-γ(ng/L) TNF-α(ng/L)
Control group 3.8±0.12 28.2±2.2
Model set 81.2±6.5 151.5±12.5
Sample set No. 1 50.6±5.3 98.7±6.2
Sample set No. 2 37.2±4.2 84.3±5.7
Sample set No. 3 23.5±4.3 61.8±4.2
Positive group 22.3±5.2 63.2±5.1
The results show that the nereis polysaccharide has a protective effect on liver injury caused by T cells, the nereis polysaccharide can reduce immune injury caused by the T cells by regulating and controlling the activity of the T cells, and in addition, the nereis polysaccharide has a protective effect on liver injury caused by the canavalin A through liver pathological histology examination.

Claims (9)

1. A method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury is characterized by comprising the following steps:
1) cleaning clamworm, freeze-drying with a freeze dryer, and pulverizing with a pulverizer to obtain clamworm powder;
2) adding clam worm powder into a phosphate buffer solution and mixing to obtain a mixture A;
3) adding trypsin to the mixture A to obtain a mixture B;
4) sequentially carrying out water bath and leaching on the mixture B, and separating to obtain a supernatant; the temperature of the water bath is 35-50 ℃, the time of the water bath is 1-8 h, the leaching temperature is 50-90 ℃, and the leaching time is 1-5 h;
5) filtering the supernatant with ceramic membrane, precipitating with ethanol to obtain precipitate, washing the precipitate, and lyophilizing to obtain nereis polysaccharide.
2. The method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury according to claim 1, which comprises the following steps: the Nereid comprises at least one of Perinereis aibuhitensis and Nereis schlegeli.
3. The method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury according to claim 1, which comprises the following steps: in the step 2), the volume ratio of the weight of the silkworm powder to the phosphate buffer is 1: 5-20.
4. The method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury according to claim 1, which comprises the following steps: the pH value of the phosphate buffer solution is 7.0-10.0.
5. The method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury according to claim 1, which comprises the following steps: in the step 3), the weight ratio of the trypsin to the silkworm powder is 1: 300-3000.
6. The method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury according to claim 1, which comprises the following steps: the enzymatic activity of the trypsin is 1000-5000U/mg.
7. The method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury according to claim 1, which comprises the following steps: in the step 4), the separation method for separating and obtaining the supernatant can adopt suction filtration or centrifugation.
8. The method for extracting nereis polysaccharide with auxiliary protection effect on immunological liver injury according to claim 1, which comprises the following steps: in the step 5), the precipitate is washed by absolute ethyl alcohol, acetone and ether respectively.
9. The nereis polysaccharide extracted by the extraction method of nereis polysaccharide as claimed in any one of claims 1-8 is applied to preparation of products with auxiliary protection effect on immunological liver injury.
CN202010532378.1A 2020-06-11 2020-06-11 Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury Active CN111647094B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010532378.1A CN111647094B (en) 2020-06-11 2020-06-11 Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010532378.1A CN111647094B (en) 2020-06-11 2020-06-11 Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury

Publications (2)

Publication Number Publication Date
CN111647094A CN111647094A (en) 2020-09-11
CN111647094B true CN111647094B (en) 2021-11-23

Family

ID=72341488

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010532378.1A Active CN111647094B (en) 2020-06-11 2020-06-11 Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury

Country Status (1)

Country Link
CN (1) CN111647094B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114921514B (en) * 2022-04-14 2024-02-23 珠海中科先进技术研究院有限公司 Hechong peptide and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61204130A (en) * 1985-03-06 1986-09-10 Kao Corp Thrombus solubilizer
CN1521188A (en) * 2003-01-28 2004-08-18 中国科学院动物研究所 Protein extracted from perinereis aibuhitensis, its preparation method and use
CN107259293A (en) * 2017-06-20 2017-10-20 中国海洋大学 A kind of method that natural is prepared from clam worm
CN108175801A (en) * 2018-01-23 2018-06-19 吉林亚泰明星制药有限公司 Chinese medicine composition with chemical damage healthcare function and preparation method thereof
CN111265552A (en) * 2018-12-04 2020-06-12 中国海洋大学 Preparation method of clam worm antithrombotic active substance

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61204130A (en) * 1985-03-06 1986-09-10 Kao Corp Thrombus solubilizer
CN1521188A (en) * 2003-01-28 2004-08-18 中国科学院动物研究所 Protein extracted from perinereis aibuhitensis, its preparation method and use
CN107259293A (en) * 2017-06-20 2017-10-20 中国海洋大学 A kind of method that natural is prepared from clam worm
CN108175801A (en) * 2018-01-23 2018-06-19 吉林亚泰明星制药有限公司 Chinese medicine composition with chemical damage healthcare function and preparation method thereof
CN111265552A (en) * 2018-12-04 2020-06-12 中国海洋大学 Preparation method of clam worm antithrombotic active substance

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"沙蚕(Perinereis aibuhitensis)硫酸多糖的结构表征及抗凝血活性研究";刘潇潇等;《中国海洋药物》;20161215;第35卷(第6期);第1-6页 *

Also Published As

Publication number Publication date
CN111647094A (en) 2020-09-11

Similar Documents

Publication Publication Date Title
KR101031605B1 (en) Manufacturing method of culture extract of ceriporia lacerata for the therapy of diabetic diseases and culture extract of ceriporia lacerata using the same
Cheng et al. Studies on anti-inflammatory activity of sulfated polysaccharides from cultivated fungi Antrodia cinnamomea
CN109276576B (en) Application of ganoderma leucocontextum polysaccharide in preparation of antitumor drugs
JP2001169774A (en) Red ganoderma lucidum spore whose germination is activated and method for producing the same
KR100663712B1 (en) A crude exopolysaccharides produced from Phellinus baumii mycellium having hypoglycemic activity and preparation method thereof
CN111040044B (en) Cordyceps militaris intracellular polysaccharide, preparation method and application thereof in regulating intestinal flora
CN108641007A (en) One kind having immunocompetent Radix Puerariae polyoses producing method
CN111647094B (en) Method for extracting nereis polysaccharide with auxiliary protection effect on chemical liver injury
CN114832022B (en) Preparation of Phellinus linteus fruiting body phenol active substances and application thereof in regulating intestinal flora and uric acid metabolism
Wang et al. Hypoglycemic effect of ethanol and ethyl acetate extract of Phellinus baumii fruiting body in streptozotocin-induced diabetic mice
CN105176844A (en) Method for bi-directional solid-state fermentation of inonotus obliquus on Chinese herbal material or Chinese medicine residues
CN110477368B (en) High-activity cordyceps sinensis powder and preparation method and application thereof
CN111253496B (en) Armillariella tabescens mycelium polysaccharide with blood sugar reducing effect
JPS5939411B2 (en) anti-animal virus agent
CN105012826B (en) A kind of intelligence development leaf extract and preparation method thereof, application
CN105535035A (en) Inonotus obliquus fermentation culture composition and preparation method thereof
CN113215198B (en) Recombinant baculovirus and preparation method and application thereof
JP2947560B2 (en) AIDS treatment and method for producing the same
KR100963511B1 (en) Exopolysaccharides for type 2 diabetes therapy from Phellinus baumii mycellium and a preparation method thereof
CN102987408A (en) Method for extracting nutritional ingredients such as free amino acids from waste cordyceps militaris cocoons
CN109988251B (en) Preparation method of needle mushroom acidic polysaccharide with antioxidant activity
CN107875179B (en) Mixed algae extract and preparation method and application thereof
CN110607245A (en) Lucid ganoderma cordyceps sinensis capsule and preparation method thereof
CN109106730A (en) It is a kind of to promote Liver Lipid Metabolism, extract of anti-inflammatory drop enzyme and preparation method thereof
CN109652479A (en) A method of improving dendrobium polysaccharide oxidation resistance

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant